Alzamend Neuro Inc (ALZN) Financials

$1.68

$0.00 (0.00%)

As on 09-Sep-2026 16:00EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

10.8

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	0.05	0.05	0.02	--	--
Gross Profit	--	-0.05	-0.05	-0.02	--	--
Operating Expenses	8.77	4.50	9.94	14.87	12.32	4.95
Operating Profit (EBIT)	-8.77	-4.50	-9.94	-14.87	-12.32	-4.95
Other Income	--	--	--	--	0.00	0.06
Profit before Tax	-8.77	-4.51	-9.95	-14.88	-12.36	-5.05
Provision for Tax	--	--	--	-0.15	0.04	0.16
Profit after Tax (Net Income)	-8.77	-4.51	-9.95	-14.88	-12.36	-5.05
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-14.88	-12.36	-5.05

Liabilities ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Shareholder's Funds	0.73	3.97	-2.59	3.05	13.35	2.01
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	1.16	0.84
Current Liabilities	1.35	0.63	3.23	2.87	1.16	0.90
Total Liabilities	2.08	4.60	0.63	5.92	14.52	2.91

Assets ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Non-Current Assets	0.31	0.43	0.18	0.08	0.10	0.35
Current Assets	1.76	4.18	0.46	5.84	14.41	2.91
Total Assets	2.08	4.60	0.63	5.92	14.52	2.91
Total Debt*	--	--	0.30	--	--	0.34
Net Current Assets	0.42	3.54	-2.77	2.97	13.25	2.01

Cashflow ($ Mln)	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Cash From Operating Activities	-8.07	-6.57	-8.27	-8.92	-6.61	-2.71
Cash Flow from Investing Activities	--	-0.30	-0.15	--	-0.11	0.10
Cash from Financing Activities	4.83	10.44	3.65	0.00	18.85	4.45
Net Cash Inflow / Outflow	--	--	--	-8.92	12.13	1.84

Financials Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
ROCE (%)	-373.18	-539.17	-2,645.56	-181.47	-157.48	-318.39
ROE (%)	-373.18	-657.17	-4,408.31	-181.47	-160.92	-356.06
ROA (%)	-262.55	-172.50	-303.88	-145.64	-141.86	-213.54
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	-309,051.48	-8,085.11
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-94.93	54.75	33.17	-20.75	-24.37	-123.82
Net Profit Growth (%)	-94.30	54.61	33.14	-20.35	-144.96	-14.79
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.08	0.89	0.01	0.35	1.14	--
Close Price ($)	1.14	0.66	7.11	82.05	153.00	--
High Price ($)	8.22	15.06	119.10	225.00	5,032.50	--
Low Price ($)	0.51	0.64	6.52	46.65	128.25	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Debt to Equity	--	--	-0.12	--	--	0.17
Short term debt to equity ratio	--	--	-0.12	--	--	0.17
Current Ratio	1.31	6.58	0.14	2.03	12.37	3.24
Quick Ratio	--	--	--	--	--	3.26
Interest Coverage	-1,324.33	-249.42	-983.83	-1,930.98	-264.71	-62.35

Operating Efficiency Ratios	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22	Apr-21	Apr-20	Apr-19	Apr-18	Apr-17	Apr-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	12,812.62	20,858.20	31,931.05	--	--
Cash Conversion Cycle	--	--	--	--	--	--